Innovation depends on freeing people to focus on meaningful work. This customer story shows how Amgen used Microsoft Copilot Studio to build a custom R&D agent in just six weeks — streamlining workflows, accelerating approvals, and helping teams innovate faster. Read the story to see how autonomous agents can drive measurable business value, and contact Intelektra Technology, Inc. to learn how to create your own agent with Copilot Studio.
What is Catalyst Copilot?
Catalyst Copilot is an intelligent agent developed by Amgen's knowledge management team using Microsoft Copilot Studio. It is designed to help drug developers quickly find and analyze vast amounts of information, reports, and resources. With its Q&A interface, Catalyst Copilot allows users to ask questions in natural language, making it easier to access the information needed to advance drug development.
How long did it take to build Catalyst Copilot?
The development of Catalyst Copilot took approximately six weeks. The main goal was to leverage AI to streamline the process of sorting and analyzing Amgen's extensive collection of curated resources, ultimately enabling drug developers to access critical information more efficiently and shorten the discovery cycle.
What impact does AI have on R&D at Amgen?
AI is transforming the research and development process at Amgen by enabling better science at scale. It helps automate parts of the scientific process and distills data to provide deeper insights. By making information more accessible and allowing for quicker analysis, AI tools like Catalyst Copilot are helping to reduce the time it takes to develop new therapies, ultimately supporting Amgen's mission to serve patients more effectively.
Sign in with LinkedIn